These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 27806937)
1. Evaluation of a protocol to optimize duration of pneumonia therapy at hospital discharge. Caplinger C; Crane K; Wilkin M; Bohan J; Remington R; Madaras-Kelly K Am J Health Syst Pharm; 2016 Dec; 73(24):2043-2054. PubMed ID: 27806937 [TBL] [Abstract][Full Text] [Related]
2. Total duration of antimicrobial therapy in veterans hospitalized with uncomplicated pneumonia: Results of a national medication utilization evaluation. Madaras-Kelly KJ; Burk M; Caplinger C; Bohan JG; Neuhauser MM; Goetz MB; Zhang R; Cunningham FE; J Hosp Med; 2016 Dec; 11(12):832-839. PubMed ID: 27527659 [TBL] [Abstract][Full Text] [Related]
3. Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study. DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L Trials; 2015 Aug; 16():355. PubMed ID: 26272324 [TBL] [Abstract][Full Text] [Related]
4. A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia. Foolad F; Huang AM; Nguyen CT; Colyer L; Lim M; Grieger J; Li J; Revolinski S; Mack M; Gandhi T; Wainaina JN; Eschenauer G; Patel TS; Marshall VD; Nagel J J Antimicrob Chemother; 2018 May; 73(5):1402-1407. PubMed ID: 29462306 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic Discordance, Uncertainty, and Treatment Ambiguity in Community-Acquired Pneumonia : A National Cohort Study of 115 U.S. Veterans Affairs Hospitals. Jones BE; Chapman AB; Ying J; Rutter ED; Nevers MR; Baker A; Dean NC; Fix ML; Singh H; Cosby KS; Taber PA; Weir CD; Jones MM; Samore MH; Butler JM Ann Intern Med; 2024 Sep; 177(9):1179-1189. PubMed ID: 39102729 [TBL] [Abstract][Full Text] [Related]
6. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital. Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB; Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688 [TBL] [Abstract][Full Text] [Related]
7. Managing antiinfective therapy of community-acquired pneumonia in the hospital setting: focus on switch therapy. Ramirez JA Pharmacotherapy; 2001 Jul; 21(7 Pt 2):79S-82S. PubMed ID: 11446522 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the impact of an antimicrobial stewardship program on the length of stay of immune-competent adult patients admitted to a hospital ward with a diagnosis of community-acquired pneumonia: A quasi-experimental study. DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L Am J Infect Control; 2016 May; 44(5):e73-9. PubMed ID: 26899527 [TBL] [Abstract][Full Text] [Related]
9. The Impact of the Duration of Antibiotic Therapy in Patients With Community-Onset Pneumonia on Readmission Rates: A Retrospective Cohort Study. Parshall DM; Sessa JE; Conn KM; Avery LM J Pharm Pract; 2021 Aug; 34(4):523-528. PubMed ID: 31645168 [TBL] [Abstract][Full Text] [Related]
10. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Houck PM; Bratzler DW; Nsa W; Ma A; Bartlett JG Arch Intern Med; 2004 Mar; 164(6):637-44. PubMed ID: 15037492 [TBL] [Abstract][Full Text] [Related]
11. Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study. Mahboub B; Al Zaabi A; Al Ali OM; Ahmed R; Niederman MS; El-Bishbishi R BMC Pulm Med; 2015 Sep; 15():112. PubMed ID: 26424530 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a pharmacy-driven methicillin-resistant Staphylococcus aureus surveillance protocol in pneumonia. Dunaway S; Orwig KW; Arbogast ZQ; Myers ZL; Sizemore JA; Giancola SE Int J Clin Pharm; 2018 Jun; 40(3):526-532. PubMed ID: 29721739 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Therapy for Pneumonia in the Emergency Department: The Impact of Clinical Pharmacists on Appropriateness. Faine BA; Mohr N; Dietrich J; Meadow L; Harland KK; Chrischilles E West J Emerg Med; 2017 Aug; 18(5):856-863. PubMed ID: 28874937 [TBL] [Abstract][Full Text] [Related]
14. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA; Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410 [TBL] [Abstract][Full Text] [Related]
15. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia. Lee RW; Lindstrom ST Respirology; 2007 Jan; 12(1):111-6. PubMed ID: 17207035 [TBL] [Abstract][Full Text] [Related]
16. Implementation of an electronic system for medication reconciliation. Kramer JS; Hopkins PJ; Rosendale JC; Garrelts JC; Hale LS; Nester TM; Cochran P; Eidem LA; Haneke RD Am J Health Syst Pharm; 2007 Feb; 64(4):404-22. PubMed ID: 17299180 [TBL] [Abstract][Full Text] [Related]
17. Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial. Uranga A; España PP; Bilbao A; Quintana JM; Arriaga I; Intxausti M; Lobo JL; Tomás L; Camino J; Nuñez J; Capelastegui A JAMA Intern Med; 2016 Sep; 176(9):1257-65. PubMed ID: 27455166 [TBL] [Abstract][Full Text] [Related]
18. Impact of an antimicrobial stewardship intervention on appropriateness of prescribing for community-acquired pneumonia in an Australian regional hospital. Bond SE; Boutlis CS; Yeo WW; Miyakis S Intern Med J; 2017 May; 47(5):582-585. PubMed ID: 28503879 [TBL] [Abstract][Full Text] [Related]
19. Comparison of processes and outcomes of pneumonia care between hospitalists and community-based primary care physicians. Rifkin WD; Conner D; Silver A; Eichorn A Mayo Clin Proc; 2002 Oct; 77(10):1053-8. PubMed ID: 12374249 [TBL] [Abstract][Full Text] [Related]
20. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia. Mortensen EM; Restrepo MI; Anzueto A; Pugh J Crit Care; 2005 Dec; 10(1):R8. PubMed ID: 16420641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]